Researchers examine cancer drug guidelines and FDA approvals
Drugs for serious or life-threatening diseases can receive expedited U.S. Food and Drug Administration (FDA) review, allowing patients to receive faster access to promising new treatments. Under the expedited review pathway ...
4 hours ago
0
0